Does pregabalin offer potential as a first-line therapy for generalized anxiety disorder? A meta-analysis of efficacy, safety, and cost-effectiveness
Publication date:
2025
Publisher version:
Citación:
Frontiers in Pharmacology, 16, (2025); doi:10.3389/fphar.2025.1483770
Collections
- Artículos [37321]